These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 15768345)
21. [Effect of methadone or naltrexone on the course of transaminases in parenteral drug users with hepatitis C virus infection]. Lozano Polo JL; Gutiérrez Mora E; Martínez Pérez V; Santamaría Gutiérrez J; Vada Sánchez J; Vallejo Correas JA Rev Clin Esp; 1997 Jul; 197(7):479-83. PubMed ID: 9411543 [TBL] [Abstract][Full Text] [Related]
22. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program. Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248 [TBL] [Abstract][Full Text] [Related]
23. Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection. Flanigan TP; Taylor LE; Mitty JA Clin Infect Dis; 2005 Apr; 40 Suppl 5():S346-8. PubMed ID: 15768346 [TBL] [Abstract][Full Text] [Related]
24. Knowledge about Hepatitis-C among methadone maintenance treatment patients in Israel. Cohen-Moreno R; Schiff M; Levitt S; Bar-Hamburger R; Strauss S; Neumark Y Subst Use Misuse; 2010; 45(1-2):58-76. PubMed ID: 20025439 [TBL] [Abstract][Full Text] [Related]
25. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M; Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278 [TBL] [Abstract][Full Text] [Related]
26. Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection. Canfield KM; Smyth E; Batki SL Subst Use Misuse; 2010 Mar; 45(4):496-514. PubMed ID: 20141461 [TBL] [Abstract][Full Text] [Related]
27. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic. Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375 [TBL] [Abstract][Full Text] [Related]
28. Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy. Schäfer A; Wittchen HU; Backmund M; Soyka M; Gölz J; Siegert J; Schäfer M; Tretter F; Kraus MR Addiction; 2009 Apr; 104(4):630-40. PubMed ID: 19335661 [TBL] [Abstract][Full Text] [Related]
29. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals. Treloar C; Newland J; Rance J; Hopwood M J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504 [TBL] [Abstract][Full Text] [Related]
30. Determinants of successful chronic hepatitis C case finding among patients receiving opioid maintenance treatment in a primary care setting. Senn O; Seidenberg A; Rosemann T Addiction; 2009 Dec; 104(12):2033-8. PubMed ID: 19922570 [TBL] [Abstract][Full Text] [Related]
31. Outcome of screening for hepatitis C virus infection based on risk factors. Mallette C; Flynn MA; Promrat K Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850 [TBL] [Abstract][Full Text] [Related]
33. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia. Vicknasingam B; Narayanan S; Navaratnam V Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801 [TBL] [Abstract][Full Text] [Related]
34. Delivering care to injection drug users coinfected with HIV and hepatitis C virus. Taylor LE Clin Infect Dis; 2005 Apr; 40 Suppl 5():S355-61. PubMed ID: 15768348 [TBL] [Abstract][Full Text] [Related]
35. Integrating treatment for hepatitis C virus infection into an HIV clinic. Clanon KA; Johannes Mueller J; Harank M Clin Infect Dis; 2005 Apr; 40 Suppl 5():S362-6. PubMed ID: 15768349 [TBL] [Abstract][Full Text] [Related]
36. High prevalence of HCV in a cohort of injectors on methadone substitution treatment. Lee KC; Lim WW; Lee SS J Clin Virol; 2008 Apr; 41(4):297-300. PubMed ID: 18191614 [TBL] [Abstract][Full Text] [Related]
37. Integrating primary care and methadone maintenance treatment: implementation issues. Herman M; Gourevitch MN J Addict Dis; 1997; 16(1):91-102. PubMed ID: 9046446 [TBL] [Abstract][Full Text] [Related]
38. Opportunities to address the hepatitis C epidemic in the correctional setting. Boutwell AE; Allen SA; Rich JD Clin Infect Dis; 2005 Apr; 40 Suppl 5():S367-72. PubMed ID: 15768350 [TBL] [Abstract][Full Text] [Related]
39. Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries. Reimer J; Schulte B; Castells X; Schafer I; Polywka S; Hedrich D; Wiessing L; Haasen C; Backmund M; Krausz M Clin Infect Dis; 2005 Apr; 40 Suppl 5():S373-8. PubMed ID: 15768351 [TBL] [Abstract][Full Text] [Related]
40. Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: a prospective multicentre study. Belfiori B; Chiodera A; Ciliegi P; Tosti A; Baldelli F; Stagni G; Francisci D Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):731-2. PubMed ID: 17625449 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]